Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension

BACKGROUND: Pharmacologic treatment for pulmonary arterial hypertension (PAH) improves exercise capacity, functional class, and hemodynamic indexes. However, monthly prescription costs often exceed $4000. We examined associations between (1) medication copayment and (2) annual household income with...

Descripción completa

Detalles Bibliográficos
Autores principales: Schikowski, Erin M., Swabe, Gretchen, Chan, Stephen Y., Magnani, Jared W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750087/
https://www.ncbi.nlm.nih.gov/pubmed/36370005
http://dx.doi.org/10.1161/JAHA.122.026620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750087/
https://www.ncbi.nlm.nih.gov/pubmed/36370005
http://dx.doi.org/10.1161/JAHA.122.026620

Ejemplares similares